Kutatási jelek – Signal Engine

Induction Paclitaxel-Cisplatin-Capecitabine for Nasopharyngeal Carcinoma — Nasopharyngeal carcinoma
Modern Gastric Cancer Care: From Diagnosis to Treatment — Gastric cancer
Hemophagocytic lymphohistiocytosis and posterior reversible encephalopathy syndrome during BRAF/MEK inhibitor therapy following immune checkpoint blockade in metastatic melanoma: a case report — Melanoma
Evaluation of the Effects of Date Palm Leaf Extract (Phoenix dactylifera) on EGFR Gene Expression in the MDA-MB-231 Breast Cancer Cell Line — Breast cancer
A Novel Therapeutic Approach for High‑Risk and Relapsed/Refractory Neuroblastoma: Dinutuximab Beta — Neuroblastoma
ctDNA Detects Postsurgical Merkel Cell Recurrence — Merkel cell carcinoma
The 25th Anniversary of Imatinib and the Evolution of Small Molecule Inhibitors — Breast cancer
Phytochemicals Targeting Inflammatory Signaling Pathways to Combat Gastric Cancer — Gastric cancer
Hodgkin Lymphoma – Brown Health Cancer Institute — Hodgkin lymphoma
AstraZeneca Ends Volrustomig Trial for First-Line Metastatic NSCLC — NSCLC
Anaplastic Large Cell Lymphoma: Overview, Subtypes of ALCL, Genetic‑Molecular Characteristics and Their Effects — Diffuse large B-cell lymphoma
Prostate Cancer — Prostate cancer
Dinutuximab Combination Therapy for High-Risk Neuroblastoma — Neuroblastoma
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer — Endometrial cancer
Lung Cancer Clinical Trials at UCSF – 2026 — NSCLC
Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA Met Endpoints of Recurrence‑Free Survival (RFS) and Distant Metastasis‑Free Survival (DMFS) in Patients With Completely Resected Stage IIB‑IV Melanoma — Melanoma
Squamous Cell Carcinoma — Head and neck squamous cell carcinoma
HER2/ERBB2 In Solid Tumors: A Practical Guide To Testing And IHC Scoring — Breast cancer
Anal Cancer — Anal squamous cell carcinoma
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma — Melanoma